Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074893/0/en/Topas-Therapeutics-TPM502-Achieves-Gluten-specific-Tolerance-Induction-Positive-Safety-Profile-in-Phase-2a-Trial-in-Celiac-Disease-Patients.html
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424473586/en/Topas-Therapeutics-Announces-Presentation-of-Phase-2a-Data-for-TPM502-in-Celiac-Disease-at-Digestive-Disease-Week-2025-in-San-Diego
17 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250317035258/en/Topas-Therapeutics-Publishes-Foundational-Data-Demonstrating-Tolerance-Induction-by-its-Proprietary-Nanoparticle-Platform-in-Frontiers-in-Immunology
15 Oct 2024
// BUSINESSWIRE
07 May 2024
// BUSINESSWIRE
26 May 2023
// CLINICAL TRIALS ARENA
https://www.clinicaltrialsarena.com/news/topas-phase-iia-celiac-disease-therapy/
ABOUT THIS PAGE